Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
06/10/1998 | CN1038645C Traditional Chinese herb medicine for preventing senility |
06/10/1998 | CN1038644C Production method for burn and scald gel |
06/10/1998 | CN1038643C Preparation method of injection for treating hircus |
06/09/1998 | US5763567 Human amino acid sequences which can bind to and/or neutralize heparin |
06/09/1998 | US5763493 Stabilized pharmaceutical |
06/09/1998 | US5763476 Sublingual or buccal pharmaceutical composition |
06/09/1998 | US5763449 Aqueous medium containing polyvinylpyrrolidone, c3-c6 polyol, ammonium glycyrrhizinate, flavors |
06/09/1998 | US5763426 Dissolving calcipotriol in organic solvent and adding water to the solution to precipitate the hydrate; storage stability; useful for treatment of psoriasis |
06/09/1998 | US5763425 Gastrointestinal toxicity side effect inhibition |
06/09/1998 | US5763423 Fungicides and viricides |
06/09/1998 | US5763416 Stimulating bone repair and regeneration |
06/09/1998 | US5763409 Stable freeze-dried formulation comprising a protein assay kit |
06/09/1998 | US5763405 Stabilized composition for oral administration of peptides |
06/09/1998 | US5763401 Stabilized albumin-free recombinant factor VIII preparation having a low sugar content |
06/09/1998 | US5763399 Revitalizing tissues with growth factor |
06/09/1998 | US5763398 Sprayable aqueous solution for drug delivery yields uniform plasma levels of the desmopressin peptide |
06/09/1998 | US5763396 Method of treating or preventing type 1 diabetes by oral administration of insulin |
06/09/1998 | US5763250 Chimeric toxins |
06/09/1998 | US5763224 Genetic engineered complementary dna |
06/09/1998 | US5763157 Biological reagent spheres |
06/09/1998 | US5762965 Vaccines against intracellular pathogens using antigens encapsulated within biodegradble-biocompatible microspheres |
06/09/1998 | US5762963 Dispersing in solid or gel vehicle in which concentration of capsaicinoid decreases from center toward periphery; for mouth, throat pain relief |
06/09/1998 | US5762961 Rapidly soluble oral solid dosage forms, methods of making same, and compositions thereof |
06/09/1998 | US5762959 Testing for explosion, implosion, diffusion, swelling and end product secretion; useful for cell grafting |
06/09/1998 | US5762958 Multilipid component ether lipid liposomes |
06/09/1998 | US5762957 Solutions with liposome vesicles, multicompartment containers |
06/09/1998 | US5762956 Multilayer drug delivery system with backings with estrogen and progestin hormones, adhesives and permeation enhancing agents |
06/09/1998 | US5762955 Method for application and maintenance of medication on body tissue |
06/09/1998 | US5762954 Comprises a pressure sensitive adhesive layer formed on a flexible support, adhesive being composed of polysiloxane and copolymer of vinyl acetate, and isosorbide dinitrate; useful for drug delivery; sustained release |
06/09/1998 | US5762953 Memory function |
06/09/1998 | US5762952 Transdermal delivery of active drugs |
06/09/1998 | US5762951 Analgesics, antacids |
06/09/1998 | US5762950 Delivery of medicines, proteins, hormones |
06/09/1998 | US5762923 Stabilized interferon alpha solutions |
06/09/1998 | US5762919 Consists of a polymerizable cyanoacrylate ester, an antimicrobially effective complex of iodine and biocompatible polymer and sulfur dioxide polymerization inhibitor |
06/09/1998 | US5762912 H2 O-resistant sunscreen/cosmetic compositions comprising hydrophilic acidic species |
06/09/1998 | US5762905 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
06/09/1998 | US5762904 Administering liposomes having covalently bound phospholipid bilayers with an aqueous core and an antigen encapsulated in and also bound to polymerized liposomes |
06/09/1998 | US5762638 Endotracheal tube; sustained drug release |
06/09/1998 | CA2157142C Treatment of diseases caused by sebaceous gland disorders |
06/09/1998 | CA2120133C Crystalline amifostine compositions and methods for the preparation and use of same |
06/09/1998 | CA2027483C Process for the preparation of an aqueous effervescent solution with emollient action on nail cuticle, composition for said process and corresponding cosmetic treatment |
06/04/1998 | WO1998023556A1 Method of production of ceramics |
06/04/1998 | WO1998023294A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation |
06/04/1998 | WO1998023292A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients |
06/04/1998 | WO1998023291A1 Percutaneous delivery system |
06/04/1998 | WO1998023287A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
06/04/1998 | WO1998023277A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesteremic agents |
06/04/1998 | WO1998023276A2 Liposomes comprising azidothymidine and lithium for treating hiv/aids |
06/04/1998 | WO1998023275A1 Use of mixtures of active substances for the production of hypocholesteremic agents |
06/04/1998 | WO1998023272A1 Compositions and methods for the treatment of gastrointestinal disorders |
06/04/1998 | WO1998023270A1 Pharmaceutical formulation |
06/04/1998 | WO1998023266A1 Method for producing a therapeutic system in the form of plaster |
06/04/1998 | WO1998023265A1 Sealing medium for composite packaging materials |
06/04/1998 | WO1998023264A1 Product |
06/04/1998 | WO1998023263A1 Ascending-dose dosage form |
06/04/1998 | WO1998023262A2 Lozenge for the modified releasing of active substances in the gastrointestinal tract |
06/04/1998 | WO1998023261A1 Method for the low-waste manufacture of diskoid moulded bodies containing active ingredients, and transdermal therapeutic systems containing same |
06/04/1998 | WO1998023260A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid |
06/04/1998 | WO1998023259A1 Agent for producing a long-lasting saturation effect |
06/04/1998 | WO1998023226A1 Biological tissue transplant coated with stabilized multilayer alginate coating suitable for transplantation and method for preparation thereof |
06/04/1998 | WO1998023151A1 Use of thrombolytic reagents for prevention of vascular disease |
06/04/1998 | WO1998010762A3 Controlled release dosage form of r-(z)-alpha-methoxyimino-alpha-(1-azabicyclo2.2oct-c-yl)acetonitrile monohydrochloride |
06/04/1998 | DE19732323A1 Combination of vasodilator, microspheres and nitro-glycerine |
06/04/1998 | DE19649535A1 Verfahren zur Herstellung eines pflasterförmigen therapeutischen Systems A method for producing a plaster-like therapeutic system |
06/04/1998 | DE19649534A1 Siegelmedium für Verbundpackstoffe Sealing medium for Composite Materials |
06/04/1998 | DE19649100A1 Verfahren zur verlustarmen Herstellung wirkstoffhaltiger scheibenförmiger Formkörper und diese enthaltende transdermale therapeutische Systeme A process for producing active ingredient-containing low-loss discoidal molding and transdermal therapeutic systems containing them |
06/04/1998 | DE19648576A1 Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt Lozenge modified release of active substances in the gastrointestinal tract |
06/04/1998 | CA2273341A1 Use of mixtures of active substances, containing phytostenols and/or phytostenol esters and potentiators, for the production of hypocholesterolemic preparations |
06/04/1998 | CA2273206A1 Lubricious self-standing (intact) gel for oral delivery of biologically-active ingredients |
06/04/1998 | CA2273055A1 Agent for producing a long-lasting saturation effect |
06/04/1998 | CA2272900A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation |
06/04/1998 | CA2272754A1 Use of mixtures of active substances for the production of hypocholesterolemic agents |
06/04/1998 | CA2272702A1 Product |
06/04/1998 | CA2272632A1 Peptides which mimic candida carbohydrate epitopes and their use in a vaccine |
06/04/1998 | CA2272437A1 Method for producing a therapeutic system in the form of plaster |
06/04/1998 | CA2269080A1 Method for the low-waste manufacture of diskoid moulded bodies containing active ingredients, and transdermal therapeutic systems containing same |
06/03/1998 | EP0845530A2 Interferon gamma inducing factor |
06/03/1998 | EP0845503A2 Liquid carotenoid compound preparations miscible with oil |
06/03/1998 | EP0845269A2 Liposomal human calcitonin gene-related peptide composition and preparation of the same |
06/03/1998 | EP0845265A1 Mucosal preparation containing physiologically active peptide |
06/03/1998 | EP0845264A1 Partial or full extract of non fermentated Camellia sinensis L. |
06/03/1998 | EP0845263A1 Capsules containing diclofenac or salts thereof in solution |
06/03/1998 | EP0845262A1 Effervescent propolis compositions |
06/03/1998 | EP0845259A2 Stable sunscreening compositions containing surface active glucose derivatives and water soluble UV-filters |
06/03/1998 | EP0845255A1 Aquous dispersion of vesicles resistant to dehydration |
06/03/1998 | EP0844909A1 Encapsulated product |
06/03/1998 | EP0844881A1 Combination osmotic and bulk forming laxatives |
06/03/1998 | EP0844872A2 Use of aromas and flavours to induce or change eating patterns |
06/03/1998 | EP0844871A1 A process for preparing microparticles through phase inversion phenomena |
06/03/1998 | EP0844870A2 Controlled release products |
06/03/1998 | EP0844869A1 Method and composition for treating asthma |
06/03/1998 | EP0844868A1 Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
06/03/1998 | EP0734285B1 Deep-bed filter for exterminating micro-organisms and inactivating viruses and its use |
06/03/1998 | EP0614527A4 Gel particle contrast media for improved diagnostic imaging. |
06/03/1998 | CN2282880Y Plaster for curing osteoproliferation |
06/03/1998 | CN1183738A Electrostatic coating |
06/03/1998 | CN1183724A Laryngeal bactericidal and antiseptic composition |
06/03/1998 | CN1183723A Transdermal therapeutic system for administering testosterone |
06/03/1998 | CN1183721A Pharmaceutical composition contg. tiagabine hydrochloride and process for its preparation |